Thought Blocking as a Manifestation of Catatonia: A Case Report.

IF 1.6 4区医学 Q3 CLINICAL NEUROLOGY

Journal of Nervous and Mental Disease Pub Date : 2024-02-01 DOI:10.1097/NMD.0000000000001727

Omar Elmarasi, Safaa Abdelhady, Yassir Mahgoub

{"title":"Thought Blocking as a Manifestation of Catatonia: A Case Report.","authors":"Omar Elmarasi, Safaa Abdelhady, Yassir Mahgoub","doi":"10.1097/NMD.0000000000001727","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Catatonia is an underrecognized disorder that has been widely described as a psychomotor syndrome, with little emphasis on its thought and cognitive dimensions. The current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision describes only motor and behavioral presentations, whereas a few catatonia scales describe only one form of thought disorders, which is thought perseveration. Thought blocking, a disorder of the thought process, is characterized by regular interruptions in the thought stream. It was described by several scholars as a sign of schizophrenia, with few reports describing thought blocking in association with catatonia. In this article, we describe the course of a patient with bipolar I disorder who presented with catatonia and demonstrated thought blocking. Her catatonic symptoms and thought blocking improved with the addition of lorazepam, recurred upon lorazepam discontinuation, and improved with resumption of lorazepam, demonstrating a clear on/off phenomenon. This report highlights the importance of recognizing thought and cognitive manifestations of catatonia, as it can enhance recognition and improve treatment.</p>","PeriodicalId":16480,"journal":{"name":"Journal of Nervous and Mental Disease","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nervous and Mental Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/NMD.0000000000001727","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract: Catatonia is an underrecognized disorder that has been widely described as a psychomotor syndrome, with little emphasis on its thought and cognitive dimensions. The current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision describes only motor and behavioral presentations, whereas a few catatonia scales describe only one form of thought disorders, which is thought perseveration. Thought blocking, a disorder of the thought process, is characterized by regular interruptions in the thought stream. It was described by several scholars as a sign of schizophrenia, with few reports describing thought blocking in association with catatonia. In this article, we describe the course of a patient with bipolar I disorder who presented with catatonia and demonstrated thought blocking. Her catatonic symptoms and thought blocking improved with the addition of lorazepam, recurred upon lorazepam discontinuation, and improved with resumption of lorazepam, demonstrating a clear on/off phenomenon. This report highlights the importance of recognizing thought and cognitive manifestations of catatonia, as it can enhance recognition and improve treatment.

查看原文本刊更多论文

思维阻滞是卡他状态的一种表现形式：病例报告

摘要：紧张症是一种未得到充分认识的疾病，被广泛描述为一种精神运动综合征，很少强调其思维和认知层面。现行的《精神疾病诊断与统计手册》第五版文本修订版只描述了运动和行为表现，而一些紧张症量表只描述了思维障碍的一种形式，即思维阻滞。思维阻滞是一种思维过程障碍，其特点是思维流经常中断。一些学者将其描述为精神分裂症的一种表现，但很少有报告描述思维阻滞与紧张症的关联。在本文中，我们描述了一名双相情感障碍 I 患者的病程。加入劳拉西泮后，她的紧张性症状和思维阻滞症状有所改善，停用劳拉西泮后症状再次出现，恢复劳拉西泮后症状又有所改善，显示出明显的开关现象。本报告强调了识别紧张症的思维和认知表现的重要性，因为这可以提高识别能力并改善治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nervous and Mental Disease 医学-精神病学

CiteScore

2.90

自引率

5.30%

发文量

233

审稿时长

3-8 weeks

期刊介绍： The Journal of Nervous and Mental Disease publishes peer-reviewed articles containing new data or ways of reorganizing established knowledge relevant to understanding and modifying human behavior, especially that defined as impaired or diseased, and the context, applications and effects of that knowledge. Our policy is summarized by the slogan, "Behavioral science for clinical practice." We consider articles that include at least one behavioral variable, clear definition of study populations, and replicable research designs. Authors should use the active voice and first person whenever possible.